Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients

NCT06153784 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

603

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia, Beta

Interventions

DRUG: Hydroxyurea and Thalidomide

Sponsor

Children's Hospital Karachi